Cholestyramine Alternatives Compared
| Cholestyramine | Entyvio | Cimzia |
|
|---|
| Cholestyramine | Entyvio (vedolizumab) | Cimzia (certolizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Pruritus of Partial Biliary Obstruction, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL. May also be prescribed... View more |
Prescription only
Entyvio is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically instead of... View more |
Prescription only
Prescribed for Ankylosing Spondylitis, Crohn's Disease - Acute, Crohn's Disease, Crohn's Disease - Maintenance, Non-Radiographic Axial Spondyloarthritis, Plaque Psoriasis, Psoriatic Arthritis... View more |
Related suggestions Crohn's Disease
Popular comparisons
|
|||||||||||||||
| More about Cholestyramine | More about Entyvio (vedolizumab) | More about Cimzia (certolizumab) | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Cholestyramine has an average rating of 8.8 out of 10 from a total of 236 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 8% reported a negative effect. |
Entyvio has an average rating of 5.8 out of 10 from a total of 138 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 32% reported a negative effect. |
Cimzia has an average rating of 6.5 out of 10 from a total of 80 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: cholestyramine side effects in more detail. |
Common side effects include:
See also: Entyvio side effects in more detail. |
Common side effects include:
See also: Cimzia side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all cholestyramine prices |
View all Entyvio prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Cholestyramine Light, Prevalite |
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
2 hours |
600 hours |
336 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 133 drugs are known to interact with cholestyramine:
|
A total of 143 drugs are known to interact with Entyvio:
|
A total of 457 drugs are known to interact with Cimzia:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
May 20, 2014 |
April 22, 2008 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.